Clinical Trial Update: Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 chemoprevention trial for uremia-associated urothelial carcinoma sponsored by National Taiwan University Hospital has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Carcinoma, Transitional Cell | Phase 2 | Status: WITHDRAWN